arrow
H

Helena Tavares de Sousa

unidade local de saúde do algarve
H指数:19
被引数:2,312

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Soluble transferrin receptor as a reliable inflammation-independent marker of iron deficiency in Crohn’s disease and ulcerative colitis

可溶性转铁蛋白受体作为克罗恩病和溃疡性结肠炎中铁缺乏的可靠且与炎症无关的标志物

2026-05-090
PRE
Distinct hepcidin patterns in Crohn's disease and ulcerative colitis: links to iron homeostasis and inflammatory activity

克罗恩病和溃疡性结肠炎中不同的肝细胞素模式:与铁稳态和炎症活性的关联

2026-03-010
PRE
Longitudinal profiles of fecal calprotectin and C-reactive protein in relation to outcomes in Crohn's disease patients on infliximab

克罗恩病患者在英夫利昔单抗治疗期间,粪钙卫蛋白和C反应蛋白的纵向变化与治疗结局的关系

2025-08-011
PRE
Inter-Rater Disagreements in Applying the Montreal Classification for Crohn's Disease: The Five-Nations Survey Study
2025-01-180
OAAI
Thiopurines have no impact on outcomes of Crohn's disease patients beyond 12 months of maintenance treatment with infliximab
2024-05-011
OAAI
The Influence of Subclinical Active Inflammation on IFX Pharmacokinetic Modeling and Disease Progression Assessment: Findings from a Prospective Real-World Study in Inflammatory Bowel Disease Patients
2024-01-192
PRE
How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?-A prospective study
2023-06-155
OAAI
Transmural remission improves clinical outcomes up to 5 years in Crohn's disease
2022-12-2713
OAAI
Subclinical Persistent Inflammation as Risk Factor for Crohn's Disease Progression: Findings From a Prospective Real-World Study of 2 Years
2022-09-018
OAAI